Lymphoma
Showing NaN - NaN of 134
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
Lymphoma Trial in United States (biological, drug, radiation)
Active, not recruiting
- Lymphoma
- rituximab
- +5 more
-
Anchorage, Alaska
- +258 more
Sep 23, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)
Completed
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
-
Tucson, Arizona
- +422 more
Aug 16, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
Greenbrae, California
- +226 more
Mar 7, 2022
Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)
Completed
- Lymphoma
- Acute Lymphoblastic Leukemia
- Apixaban
- No systemic anticoagulant prophylaxis
-
Phoenix, Arizona
- +95 more
Feb 10, 2022
Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))
Recruiting
- Leukemia
- +5 more
- Bone Marrow Transplant (BMT)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell
Active, not recruiting
- Acute Leukemia
- +3 more
- Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
- +5 more
-
Birmingham, Alabama
- +38 more
Oct 25, 2021
Lymphoma Trial in Washington, Baltimore (rituximab, sargramostim, EPOCH regimen)
Withdrawn
- Lymphoma
- rituximab
- +7 more
-
Washington, District of Columbia
- +1 more
Oct 19, 2021
Lymphoma Trial in United States (ACTR707, rituximab)
Terminated
- Lymphoma
- ACTR707
- rituximab
-
Gilbert, Arizona
- +10 more
Oct 4, 2021
Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)
Unknown status
- Lymphoma
- immunoscintigraphy
- technetium Tc 99m epratuzumab
-
Los Angeles, California
- +7 more
Aug 12, 2021
Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)
Unknown status
- Lymphoma
- immunoscintigraphy
- technetium Tc 99m epratuzumab
-
Los Angeles, California
- +7 more
Aug 12, 2021